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In sepsis, dysregulated immune responses to infections cause damage to the host.
Previous studies have attempted to capture pathogen-induced leukocyte responses.
However, the impact of mediators released after pathogen-leukocyte interaction
on endothelial cells, and how endothelial cell responses vary depending on the
pathogen-type is lacking. Here, we comprehensively characterized the transcriptomic
responses of human leukocytes and endothelial cells to Gram negative-bacteria, Gram
positive-bacteria, and fungi. We showed that whole pathogen lysates induced strong
activation of leukocytes but not endothelial cells. Interestingly, the common response
of leukocytes to various pathogens converges on endothelial activation. By exposing
endothelial cells to leukocyte-released mediators, we observed a strong activation
of endothelial cells at both transcription and protein levels. By adding IL-1RA and
TNF-α antibody in leukocyte-released mediators before exposing to endothelial cells, we
identified specific roles for IL-1 and TNF-α in driving the most, but not all, endothelial
activation. We also showed for the first time, activation of interferon response by
endothelial cells in response to leukocyte-released mediators, independently from IL-1
and TNF-α pathways. Our study therefore, not only provides pathogen-dependent
transcriptional changes in leukocytes and endothelial cells during infections, but
also reveals a role for IFN, together with IL1 and TNFα signaling, in mediating
leukocyte-endothelial interaction in infections.
Keywords: leukocyte-endothelial interaction, sepsis, bacterial infection, fungal infection, leukocyte
transcriptomes, endothelial transcriptomes, interferon pathways
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INTRODUCTION
Sepsis is a life-threatening organ dysfunction caused by a
dysregulated host response to infection (1). Despite advances
in early recognition, sepsis affects around 30 million people
worldwide every year and has a mortality rate of 20–40% (2).
Sepsis is known to be a heterogeneous syndrome with various
outcomes that depend on pathogenic characteristics as well
as on host susceptibility. Despite decades of research, sepsis
pathophysiology remains poorly understood. However, it is
known that an interaction between innate immune cells and
endothelial cells is central for the pathogenesis of sepsis, with
recognition of infectious pathogens as a first step toward full
activation of inflammation. The activated cells interact with
different blood compartments and organ cell types such as
platelets, adaptive immune leukocytes, and parenchymal cells
(3). Failure in properly regulating these cellular responses and
interactions often leads to multiple organ failure, and even
mortality in sepsis patients.
Recent studies have employed transcriptomic approaches to
characterize the global response of immune cells, particularly
peripheral blood mononuclear cells (PBMCs) to various
pathogens. After microbial recognition, innate immune cells
are prone to inflammatory and stress responses while reducing
apoptosis signaling, resulting in the release of cytokines,
chemokines, and damage-associated molecular pattern factors
into the circulation (4). Gene expression profiles of whole
blood from human volunteers challenged with a low dose of
endotoxin also showed a reduction in integrin-α and integrin-
β chain expression, indicating changes in the host immune
system in adherence to and interaction with other cell types
(5). Nevertheless, we still know relatively little about the impact
of these transcriptomic alterations of immune cells on its
interaction with other cell types, specifically on endothelial cells.
Endothelial cells are a monolayer of cells lining the blood
vessel that is actively involved in homeostasis as well as
interacting with immune cells to regulate inflammation (6). The
endothelium is activated not only by inflammatory cytokines
such as IL-1β and TNF-α (7), but also by endotoxins such as
lipopolysaccharides (LPS) via the Toll like receptor-4 (TLR4) and
RIG-I pathways (8, 9). Upon activation, the endothelium secretes
cytokines (IL-6 and IL-8) and expresses adhesion molecules
(E-selectin, VCAM-1, and ICAM-1) to facilitate leukocyte
extravasation. The increased influx of neutrophils andmonocytes
into the tissue during sepsis could then indirectly lead to
tissue damage by secreting exaggerated amounts of inflammatory
mediators and reactive molecules (10). In the context of sepsis,
the endothelium can be exposed to different types of infectious
pathogens such as bacteria (Streptococcus pneumoniae) or fungi
(Candida albicans). However, the impact of these pathogens on
endothelial activation has not been studied systematically.
Given the ability of endothelial cells to respond to pathogens
and interact with immune cells, it is important to characterize
endothelial responses upon exposure to the mixture of various
cytokines, chemokines and proteins secreted by activated
immune cells, as well as to different types of infectious pathogens.
Therefore, in this study, we applied a two-step in vitro stimulation
model to comprehensively characterize: (1) the transcriptomic
responses and inflammatory proteins secreted by PBMCs in
response to a variety of stimulating pathogens, including Gram-
negative bacteria, Gram-positive bacteria, and fungi; and (2) the
transcriptomic responses of endothelial cells exposed to humoral
signals from activated PBMCs that were exposed to various
pathogens. Through this work, we were able to identify the role
of IL-1 and TNF-α in driving most, but not all, endothelial
activation. We show that, independent of IL-1 and TNF-α,
interferon (IFN) pathways in endothelial cells are strongly
induced by humoral signals from activated leukocytes.
Our study provides crucial insights into the role of pathways
mediating leukocyte-endothelial interactions, including IL-1,
TNF-α, and IFN pathways. Further studies are required to
validate the function of IFN pathways in endothelial function and
IFN’s role in determining sepsis progression.
MATERIALS AND METHODS
PBMC Isolation
Venous blood samples were collected from healthy volunteers.
All donors provided written informed consent. Ethical
permission for this study was approved by the Ethical Committee
of Radboud University Nijmegen (nr 42561.091.12). Blood was
collected in EDTA tubes (BD vacutainer). PBMCs were
quickly isolated within 3 h of collection. Blood was diluted
with 1 volume of DPBS (Gibco, ThermoFisher Scientific)
before adding to Ficoll-Paque (Pharmacia Biotech). Gradient
centrifugation was performed for 30min at 400 g, using no
brake. After centrifugation, the layer containing PBMCs was
collected using a Pasteur pipette. PBMCs were washed twice
with PBS, counted (BioRad cell counter), and adjusted to
reach the final concentration of 2 million cells/ml in RPMI
1640 (Gibco, ThermoFisher Scientific), supplemented with
10% heat-inactivated Fetal Cow Serum (Gibco, ThermoFisher
Scientific), gentamicin 10 mg/ml, L-glutamine 10mM, and
pyruvate 10mM. Cells were seeded into wells to settle overnight
before stimulation.
PBMC Stimulation
To study PBMC transcriptomes upon five types of heat-killed
pathogens, PBMCs were stimulated with various pathogens,
including heat-killed Streptococcus pneumonia (ATCC 49619,
serotype 19F) at 1 million cells/ml, heat-killed C. albicans
(ATCC MYA-3573, UC 820) at 1 million cells/ml, heat-
killed Aspergillus fumigatus (V05-27) at 1 million cells/ml,
Mycobacterium tuberculosis (H37Rv) at 1 million cells/ml,
and heat-killed Pseudomonas aeruginosa at 1 million cells/ml
(11). Cells were also incubated with RPMI 1640 only as a
negative control. RNA was isolated from PBMCs at 4 and 24 h
after stimulation.
Endothelial Cell Culture and Direct
Stimulation
Primary Human Umbilical Vein Endothelial Cells (HUVECs)
were used to study the response of endothelial cells upon
infection. Pooled donor HUVECs were purchased (Lonza,
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Breda, the Netherlands) and cultured in EBM-2TM medium
(Lonza) supplemented with EGM-2MV SingleQuot Kit
Supplements & Growth Factors (Lonza) at 37◦C, 5% CO2 and
saturating humidity. Passage 3–5, confluent cells were used for
all experiments.
For direct stimulation, HUVECs were stimulated with either
heat-killed Streptococcus pneumonia (ATCC 49619, serotype
19F) at the concentration of 1 million cells/ml, heat-killed C.
albicans (ATCC MYA-3573, UC 820) at 1 million cells/ml, LPS
(Escherichia coli serotype O26:B6, Sigma, St. Louis, MO, USA)
at 1,000 ng/ml, IL-1β (Biosource Netherlands, Etten-Leur, The
Netherlands) at 10 ng/ml, TNF-α (Biosource Netherlands) at
10 ng/ml for 6 or 24 h.
Leukocyte-Endothelial Cell Interaction
To study the effect of soluble factors released by activated PBMCs
on endothelial cells, PBMCs were diluted to 2 million cells/ml
and stimulated with three different types of pathogens at the ratio
of 2 cells:1 pathogen heat-killed Streptococcus pneumonia, heat-
killed C. albicans and LPS (10 ng/ml). RPMI medium was used
as the negative control. Supernatants were collected after 24 h of
stimulation, aliquoted, filtered (0.45µmfilter) and kept at−20◦C
before either exposing to HUVECs or measuring cytokine levels
with OLINK and ELISA.
The supernatants from activated PBMCs were thawed
overnight at 4◦C and warmed up shortly to 37◦C. Polymyxin B
(InvivoGen, Toulouse, France) was added to the supernatants
at a final concentration of 100µg/ml to neutralize residual LPS
(9). The supernatants were then added to HUVECs. To study
the effect of IL-1 and TNF-α secreted by activated PBMCs on
endothelial cells, LEAF-purified TNF-α Antibody (BioLegend,
San Diego, CA, USA) and/or IL-1RA (Anakinra) were added to
the supernatants at the final concentration of 4 and 300 ng/ml,
respectively, incubated at 37◦C for 1 h before adding to HUVECs
(https://patents.google.com/patent/US7227003). HUVECs were
incubated with the supernatants from stimulated PBMCs for 6
and 24 h. At the time of harvesting, conditioned medium, and
cells were collected for ELISA, RNA isolation and flow cytometry.
RNA Isolation
Cells were harvested and lysed in lysis buffer from the MirVanva
MagMax RNA isolation kit Applied Biosystems Nieuwerkerk aan
den IJssel, The Netherlands. RNA was isolated according to the
manufactures instructions. RNA concentration was measured
based on Optical density (OD260) using the Nanodrop machine
(NanoDrop Technologies, Rockland, ME, USA). RNA integrity
was determined using the Bioanalyzer (Agilent D2000). All
samples had RIN score> 9.
RNA Sequencing and Pathway Enrichment
Analysis
For PBMC sequencing, 1,000 ng of total RNA (RIN score ≥ 9)
were submitted for RNA library preparation using the NEXTflex
TM Rapid Directional RNA-seq kit, BioScientific. NGS libraries
were enriched for polyA tail RNA. Samples were sequenced using
the Illumina NextSeq 500 platform, single-end read. Samples
were randomly assigned into different flows and sequenced
to reach 12–15 million reads per sample. Sequencing reads
were then mapped to the human genome using STAR (version
2.3.0) with a reference to Ensembl GRCh37.71. Read counts
per gene was quantified by Htseq-count, Python package HTseq
(version 0.5.4p3) using the default union-counting mode (The
HTSeq package, http://htseq.readthedocs.io/). For endothelial
RNA sequencing. 500 ng of total RNA (RIN score ≥ 9) were sent
to GenomeScan, Leiden, The Netherlands for analysis. mRNA
(polyA) enriched libraries were constructed, and sequenced with
the NextSeq 500 platform, single end, 75 bp with 15–20 million
reads/ sample. Fragments were aligned using Hisat2. Raw counts
were calculated with String Tie. Pathway analysis was performed
using gene set enrichment analysis on differential expressed
genes using the default setting from ConsensusPathDB-human
database (http://cpdb.molgen.mpg.de).
Flow Cytometry
To determine the protein expression of adhesion molecules
on the HUVEC membrane, cells were washed with PBS,
detached using trypsin, washed with PBS, and re-suspended
in ice-cold FACS buffer (PBS supplemented with 5% FCS).
The cells were divided equally into separate FACS tubes. The
cells were stained using the following antibodies: PE-conjugated
anti-human E-selectin (CD62E) (Biolegend), APC-anti human
VCAM-1 (CD106) (Biolegend), FITC- anti human ICAM-1
(CD54) (Biolegend), and IgG isotope controls (IgG isotope
controls, Biolegend) for 30min on ice. The cells were washed
once and resuspended in FACS buffer. Samples were analyzed
using a MACSQuant Analyzer 10 system (Miltenyi Biotech,
San Diego, CA, USA). Multi-color compensation was calibrated
using positive control cell population (LPS activated HUVECs).
Data were presented as the Geometric Mean of Fluorescence
Intensity (MFI).
ELISA
Cytokine levels secreted by PBMCs and/or HUVECs were
determined using the ELISA Duo kits, IL-6 (R&D), IL-1β (R&D),
IL-1α (R&D), TNF-α (R&D) and IL-8 (R&D), according to the
manufacturer’s instructions. Data were presented as pg/ml.
OLINK
To further quantify the levels of other secreted proteins upon
various stimulations, supernatant samples were analyzed by
proximity extension assay provided commercially by Proseek
Multiplex analysis (Olink Bioscience, Uppsala, Sweden) using
their inflammation panel (https://www.olink.com/products/
inflammation). In brief, for each marker, a pair of nucleotide
probe-conjugated antibodies was incubated with the sample.
Only when binding to target antigen presented in the sample, the
pair of probes are in proximity, enabling the probes to anneal
and amplify during Realtime PCR. Internal control was used to
minimize variation within runs. The output data is an arbitrary
unit of normalized log2 expression scale (NPX- normalized
protein expression). The NPX value is different for each protein
due to the sensitivity of each of the probes. The range and
estimated inversion from NPX value to absolute amount (ng/µl)
can be found in Olink website. Data were shown as NPX value.
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Statistical Methods
For RNAsequencing data, differentially expressed genes were
identified by statistical analysis using the DESeq2 package
from Bioconductor. A statistically significant threshold (FDR
P ≤ 0.05 and fold change ≥ 2) was applied. For pathway
analysis, significant threshold (FDR <= 0.05) was used to
identify significant pathways. For FACS and ELISA, graphs
and statistical tests were performed using GraphPad Prism
software v.6 (GraphPad Prism Software Inc., San Diego,
CA, USA). Differences were considered significant when
p < 0.05. ELISA and FACS data were checked for normality
distribution with Omnibus K2 test. One-way ANOVA with
Turkey multiple comparison tests were performed to identify
significant differences between conditions and control for
direct stimulation.
RESULTS
Pathogen-Dependent Early and Late
Transcriptional Responses of PBMCs
To identify pathogen-dependent transcriptional responses
in leukocytes, we first studied the global transcriptional
changes of human PBMCs upon various stimuli. PBMCs were
isolated from eight healthy individuals and stimulated by five
types of pathogens: Pseudomonas aeruginosa (P. aeruginosa),
Streptococcus pneumoniae (S. pneumonia), Mycobacterium
tuberculosis (M. tuberculosis), Candida albicans (C. albicans),
and Aspergilus Fumigatus (A. fumigatus) for 4 and 24 h. We
performed RNA sequencing followed by differential expression
analysis to identify differentially expressed (DE) genes between
stimulated and un-stimulated samples (RPMI control). This
identified 4,189 protein-coding genes that were significantly
differentially regulated in response to at least one of the
stimulations (Adjusted P ≤ 0.05, FC ≥ 2-fold). Among those
DE protein-coding genes, we observed both common genes,
which respond to all pathogens, and pathogen-specific genes
at 4 h (Figure 1A) and 24 h of stimulation (Figure 1B). We
observed that the Gram-negative bacteria P. aeruginosa altered
the expression levels of more than 2,000 genes at 4 h. In contrast,
we found fewer genes to be differently regulated in response to
C. albicans (666 genes) and Gram-positive bacteria (956 genes)
at 4 h (Supplemental Figure S1A). At 24 h, we found more
genes being differentially regulated by different pathogens. This
indicates that P. aeruginosa is one of the stronger inducers of
early responses in leukocytes (Supplemental Figure S1B). In
contrast, C. albicans induced three times more genes, indicating
it is a strong immune stimulator at later time points.
Next we performed pathway enrichment analyses on
pathogen-specific DE genes (Supplemental Table S1). Pathway
enrichment analysis of P. aeruginosa-specific genes at 4 h
showed significant enrichment of DE genes for several immune
pathways, including cytokine responses, IFN signaling, TNF
signaling, IL-1 signaling, apoptosis, and inflammasome
activation. Interestingly, S. pneumonia-specific DE genes are
enriched for the suppression of inflammatory pathways and
TCR signaling at both 4 and 24 h. In contrast, C. albicans specific
pathways are enriched for antigen presentation and initiating
inflammatory responses (Supplemental Table S1). Overall, the
distinct pathways enriched with DE genes by each pathogen
highlight the induction of different inflammatory responses
in PBMCs: TNF signaling, IL-1 signaling, and IFN signaling.
The transcriptome response, thus reflects complex cytokine
responses of PBMCs that are needed to interact with different
cell types, depending on the type of infectious pathogens.
Common Responses of PBMCs to a Variety
of Pathogens Converge on Endothelial
Cells
Next we tested whether common genes that are differentially
regulated in response to all pathogens are enriched for particular
pathways. At 4 h of stimulation, there were 123 genes that
responded to all five pathogens (Figure 1C). Of note, some
of the pathways that were activated at the early time point
(4 h) also remained active at 24 h. Among 123 common
genes that are either induced or repressed at 4 h, 50% show
consistent differences at 24 h. Interestingly, chemokine genes
such as CCL2, CCL3, CCL7, CXCL8 (IL-8), and IL-10 are more
strongly induced at 24 h, indicating the role of chemokine
signaling in communicating with different cell types at later time
points (Supplemental Figure S2). Pathway enrichment of the
123 common genes showed the enrichment of genes involved
in initiating chemokine responses as well as in arranging cell-
cell interaction, and assembly of cell junctions. Interestingly,
expression levels of the cadherin genes CDH5 and CDH6
are reduced, suggesting a repression of adherens junction
interactions (Figure 1D). At 24 h, we found 236 DE genes shared
between all pathogens (Figure 1E). The up-regulated genes were
enriched for the interaction of immune cells with the extracellular
matrix and vascular cell wall, as well as for regulation of
trafficking through gap junction (Figure 1F). These results show
that the common pathways induced in leukocytes in response to
different sepsis-causing pathogens are also involved in regulating
the interaction of immune cells with the cellular matrix and in
interaction with endothelial cells at the vasculature. Endothelial
cells are known as a non-classical innate immune cell type that
recognize and respond to bacterial lipopeptides via Toll-like
receptor signaling. Endothelial responses to infection produce
cytokines and chemokines, alter leukocyte migration, facilitate
coagulation and, ultimately, contribute to controlling infection
(12). Therefore, based on the complexity of cytokine signals
released by leukocytes to different types of infection and their
convergent effect on endothelial cells, it is crucial to understand
the impact of leukocyte humoral signals on endothelial cells and
their coordination to fight against infections.
Minimal Impact of Heat-Killed Pathogens
on Endothelial Inflammatory Responses
In sepsis, endothelial barrier disruption is commonly observed
in septic shock where organ function fails (13). However, not
much is known about whether different types of pathogens
can activate vascular endothelial cells directly. We therefore
investigated if HUVECs can respond to direct stimulation
by LPS, heat-killed S. pneumoniae or heat-killed C. albicans.
Transcriptome profiles of HUVECs after 6 h direct stimulation
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FIGURE 1 | Core transcriptional responses of PBMC to different stimulations affect EC. The expression levels (log2-fold change) of differentially expressed (DE) genes
in PBMC upon stimulation at (A) 4 h and (B) 24 h. Color represents log2-fold change value. Number of shared and specific DE genes at (C) 4 h and (E) 24 h. Pathways
enriched for common DE genes at (D) 4 h and top-10 pathways enriched at (F) 24 h. Orange and blue indicate pathways enriched by upregulated and suppressed
genes, respectively. Data are represented as (A,B) mean expression levels from PBMC isolated from eight individuals (D,F) –log10 q-value.
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FIGURE 2 | Heat-killed pathogens do not directly induce EC activation. (A) Mean RNA expression level (VST) of 213 DE genes responding to either LPS, S.
pneumoniae or C. albicans on EC. Color scales by VST value, ranging from weak to strong expression (6–16). Data are represented as mean of three replications.
(B) Number of shared and unique genes induced in EC upon stimulation. (C) List of 16 common DE genes (with protein names), and their pathway enriched by
Reactome. (D,E) Protein expression levels of E-selectin, VCAM-1, ICAM-1, IL-6, and IL-8 in EC at 6 and 24 h after stimulation with LPS, S. pneumoniae (SPneu) and
C. albicans (C.alb), respectively. E-selectin, VCAM-1 and ICAM-1 were measured by flow cytometry, data were presented as Geometric Mean Florescence Intensity
(MFI). IL-6 and IL-8 were measured by ELISA, data were presented as pg/ml. Data are shown as mean (SD), representative for three independent experiments.
****p < 0.0001.
showed strong response of HUVECs to LPS in contrast to
heat-killed pathogens (Figures 2A,B). We found 203 genes
that significantly responded to LPS, whereas only 22 and
26 genes were induced by S. pneumoniae and C. albicans,
respectively (Figure 2B). There were 16 genes in HUVECs
that responded to all stimulations (Figure 2C), and these were
enriched for alterations in semaphorin interaction. RNAseq data
also showed significant differences in the expression levels upon
stimulation of the inflammatory markers: IL-8 (CXCL8), E-
selectin (SELE), and VCAM-1 (VCAM1). However, the small
changes in RNA levels of these markers upon S. pneumonie
and C.albicans stimulation did not significantly alter protein
levels (Figures 2D,E). Therefore, direct activation of endothelial
cells by pathogens has minimal effect on inducing endothelial
cell inflammatory responses. We therefore hypothesized that
in response to pathogens, the leukocytes produce mediators
that activate endothelial cells much more strongly than direct
pathogen stimulation.
Leukocyte-Released Mediators
Significantly Induce Endothelial Cell
Activation
During bloodstream infection, endothelial cells are in contact
with both infectious pathogens and immune cells. RNAseq
data from activated PBMCs indicated up-regulation of several
cytokine pathways upon stimulation with different types of
pathogens. We therefore investigated the effect of cytokines
from stimulated immune cells on endothelial cells. To mimic
the humoral interaction between immune cells and endothelial
cells, we first stimulated PBMCs with either LPS, S. pneumoniae
or C. albicans for 24 h, then harvested the supernatant,
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neutralized the LPS-trace by polymyxin B (9), and exposed
HUVECs to the supernatant containing cytokine signals from
the activated PBMCs. After 6 h of exposure, we measured the
expression levels of inflammatory markers on endothelial cells.
We observed strong activation of endothelial cells at protein
level. Interestingly, whereas direct exposure of HUVECs to
heat-killed pathogens did not induce endothelial activation, the
exposure to supernatants from S. pneumonia-stimulated PBMCs
(Spneu_Sup) and C. albicans-stimulated PBMCs (C.alb_Sup)
significantly induced the expression levels of adhesion molecules
(E-selectin, VCAM-1, and ICAM-1) and cytokines (IL-6 and
IL-8) (Figures 3A–C). Endothelial cells, together with PBMCs,
are the main source of IL-6. We conclude that endothelial cells
become activated by heat-killed pathogens via cytokines and
other inflammatory mediators released from activated PBMCs.
To further characterize the genes and pathways activated
in HUVECs outside the conventional markers, we performed
RNAseq to look at the transcriptome of endothelial cells exposed
to PBMC supernatants (Figures 3D,E). We found 72 genes
induced by LPS_Sup, 180 genes induced by Spneu_Sup and
222 genes induced by Calb_Sup. Among these, 65 genes are
shared between all supernatants, which is 90% of the LPS_Sup
responding genes, 36% of Spneu_Sup responding genes, and
29% of Calb_Sup responding genes (Figure 3E). Among the 65
shared genes, 60 are uniquely induced by supernatant and five
are also commonly induced by direct stimulation (CXCL8, F3,
RND1, SELE, VCAM1). Pathway enrichment for the 60 unique
genes shows a strong enrichment for cytokine signaling, IFN
signaling, IL-1 signaling and TNF signaling (Figure 3F and
Supplemental Figure S3). Since LPS, hence LPS_Sup, cannot
represent the complexity of PBMC responses to bacteria, we also
looked at the genes shared between Spneu_Sup and Calb_Sup.
Interestingly, here we found 85 commonly responding genes,
which is 47% of the S.pneu_Sup and 38% of the Calb_Sup
responding genes. Pathway enrichment for these genes also
indicated strong enrichment for cytokine signaling, particularly
for interleukins, IFN, and IL-1 (Figures 3G–I). Altogether,
this evidence suggests that the activation of endothelial cells
by mediators released from PBMCs is mostly shared and
independent of the type of infectious pathogens.
IL-1 and TNF-α Are Major Mediators, Yet
There Are Contributions From Other
Cytokines Secreted by PBMCs on EC
Activation
Although blocking of IL-1 or TNF-α has resulted in inconsistent
results due to study design, recent clinical trials in stratified
patients have shown IL-1- or TNF-blocking therapy to be
effective in improving sepsis survival (14–16). Since endothelial
cells express receptors for IL-1 (17, 18) and TNF-α (19), we were
intrigued to investigate the effect of IL-1 and TNF-α present in
the PBMC-supernatant on inducing endothelial activation, and
if other PBMC secreted-mediators play a role. Before adding
the supernatants to HUVECs, we either neutralized TNF-α in
the supernatants with a TNF-α blocking antibody or blocked
the effect of IL-1α and IL-1β by adding IL-1RA (Anakinra),
or both. The blocking dose efficiency was 100% for IL-1 and
approximately 75% for TNF-α (Supplemental Figure S3). We
found that TNF-α secreted by activated PBMCs was the main
mediator for endothelial expression of adhesion molecules (E-
selectin, VCAM-1, and ICAM-1). However, it was not the
sole mediator. IL-1α and/or IL-1β also activated the expression
of E-selectin, but not VCAM-1 and ICAM-1 (Figures 4A–C).
Moreover, neutralization of both TNF-α and IL-1 in the
supernatant secreted by activated PBMCs almost completely
inhibited endothelial activation, indicating an additive effect of
TNF-α and IL-1 on endothelial cell activation (Figures 4A–C).
On the other hand, TNF-α had no effect on the induction of
IL-6 secretion by endothelial cells. This is in contrast to IL-1
blockage, which inhibited endothelial IL-6 secretion. However,
the extent to which IL-1 regulates IL-6 expression on endothelial
cells depends on other mediators that are co-secreted by PBMCs
in response to a specific pathogen. Neutralization of IL-1 in
the PBMC supernatant reduced the amount of IL-6 secretion
only in the case of C. albicans. Of note, cytokine levels secreted
by endothelial cells do not completely return to baseline levels
even after blocking TNF-a and IL-1, which suggests that other
pathways may be involved in producing endothelial cytokines at
a marginal level.
Up-Regulation of IFN Pathways in
Endothelial Cells by Humoral Mediators
From PBMCs Is Independent of IL-1 and
TNF-α
As IL-1 and TNF-α are the major mediators that induce
a strong response in endothelial cells, we tested the effect
of blocking IL-1 and TNF-α on endothelial transcriptional
responses (Figures 4D–F). Comparison of DE genes in HUVECs
exposed to supernatants before and after TNF-α Ab and IL-
1RA treatment revealed differential expression of 15, 47, and
81 genes in the context of LPS, S. pneumoniae and C. albicans,
respectively (Figure 4E). Interestingly, these genes were shared
between different supernatants and are enriched for IFN-α/β and
IFN-γ pathways (Figure 4F). The enrichment was much stronger
in the case of C. albicans stimulation suggesting C. albicans is one
of the strong stimulators of IFN-inducing mediators. Notably,
in the context of S. pneumoniae and C. albicans, we found the
differential expression both IFN-induced genes and the upstream
genes, including DDX58 (RIG-I), NLRC5, and TLR3. We also
found the expression of IFN receptor genes in HUVECs at RNA
levels (Supplemental Figure S4A). These results suggest that the
IFN-α/β and IFN-γ pathways are up-regulated in endothelial
cells by mediators released by leukocytes in response to sepsis-
causing pathogens, and are independent on IL-1 and TNF-α.
Validation of an IL-1- and
TNF-α-Independent Effect of IFN-α/β/γ on
Endothelial Response
In view of the above data, to test if IL-1- and TNF-α-independent
effect on endothelial cells was mainly driven by IFN-α/β/γ, we
made use of previously published microarray gene expression
data (20). We compared whether the genes induced by direct
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FIGURE 3 | Leukocyte-mediators significantly induce EC activation. (A–C) Protein levels of E-selectin, VCAM-1, and ICAM-1 measured by flow cytometry, and
secreted IL-6 and IL-8 measured by ELISA on EC after 6 h exposed to direct stimulation (first 2 columns) and to PBMC medium (other columns). Data were presented
as Mean florescence Intensity (MFI) for E-selectin, VCAM-1 and ICAM-1 and pg/ml for IL-6 and IL-8. For IL-6 and IL-8, the amount of cytokines presented in PBMC
medium before adding to EC were plotted in the 3rd and 4th column, whereas the amount of total cytokines after exposure to EC were plotted in the 5th and 6th
column. Colors represent three different individuals of whom PBMC were isolated. (D) RNA expression levels (VST) of 255 DE genes in EC induced by PBMC medium.
(E) The number of shared and unique DE genes between various conditions. (F) Top five pathways enriched by 60 common genes induced by all PBMC medium.
(G–I) Top 5 pathways enriched by genes responded to (G) Spneu_Sup and Calb_Sup, (H) only Calb_Sup, and (I) only Spneu_Sup. Data are shown as (A–C)
representative of three independent experiments (mean and SD) (D,E) mean from three biological replications (F–I), –log10 of q-value. **p < 0.01, ***p < 0.001,
****p < 0.0001.
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FIGURE 4 | IFN pathways remain active in EC after neutralization of IL1 and TNFα in leukocyte-mediators. (A–C) Protein abundance on EC after exposure to
(A) LPS-activated PBMC medium (B), S. pneumonia-activated PBMC medium (C), C. albicans-activated PBMC medium with, or without IL-1RA and TNF-α Ab for
6 h. For cytokines, the amount of cytokines presented in PBMC medium before adding to HUVECs were plotted before the dash line whereas that after 6 h exposed to
HUVECs were plotted behind the dash line. Colors of dots indicate different PBMC donors. (D) RNA expression levels (VST) of 255 DE genes activated in EC by
PBMC medium with or without blocking. (E) Percentage of genes independent from IL-1 and TNF-α. Number of genes that are dependent (dark shade) and
independent (light shade) of IL1 and TNF α. (F) Genes expressed independent of IL-1 and TNF-α are strongly enriched for IFN signaling. Data are shown as
(A–C) mean (SD), representative of three independent experiments (D), mean expression value of 3 biological replications (F), –log10 of q-value. *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001.
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FIGURE 5 | Validation of IFNs effect on EC. (A) Number share and unique genes induced by IFN-α on ECs (20) and leukocyte- mediators after blocking of both IL-1
and TNF-α on ECs. (B–D) Protein levels of IFN-α downstream genes: CXCL11 and TRAIL, and IFN-gamma produced by stimulated leukocytes (before the dash line)
and EC (after the dash line) in the supernatants, measured by Olink®. Data are shown as mean (SD), represented for two independent experiments. Colors correlate
to three donors of whom PBMCs were isolated.
activation of HUVEC by IFN-α/β/γ are also induced in our
experiment after blocking IL-1 and TNF-α. We found that
62% of genes induced in HUVECs after exposure to Candida-
induced supernatant with IL-1 and TNF-α blocking agents are
also present in the list of differential expressed genes induced
by IFN-α (Figure 5A). We also found expression of IFN-β and
IFN-g in PBMCs in response to stimulation at RNA levels
(Supplemental Figure S4B). Altogether, it suggests the presence
of IFN-α in the mediators released by leukocytes. We also
found high levels of circulatory IFN-γ in the supernatants from
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Candida-stimulated leukocytes (Figure 5D). In addition, we also
confirmed the up-regulation chemokines such as CXCL11 and
TRAIL which is known to be present at higher levels in the
endothelium following treatment with IFN-α (20). Of notice,
protein levels of these proteins are not dependent on IL-1 and
TNF-α (Figures 5B–D).
DISCUSSION
Sepsis is not a homogeneous disease, but rather life-threatening
organ dysfunction syndrome caused by a dysregulation of
host response to infection (1). Given the heterogeneity of
sepsis patients, many clinical trials targeting the hyper-
inflammatory response in sepsis, including corticosteroids, and
anti-cytokine therapies (e.g., anti-IL1 and anti TNF-α) have
yielded disappointing results (21, 22). Understanding the impact
of the complex interactions between causal cell types in a
pathogen-specific manner is therefore crucial to delineate the
molecular basis of heterogeneity in sepsis outcome. In the present
study, we applied an integrative genomics approach to not only
characterize the global transcriptional response of leukocytes
and endothelial cells to many sepsis-causing pathogens, but
to also identify important molecular pathways induced during
leukocyte-endothelium cross-talk in regulating overall immune
response in sepsis.
First, to identify leukocyte responses to three classes of
infectious pathogens (Gram-negative bacteria, Gram-positive
bacteria, and fungi) we assessed the transcriptional response
of PBMCs to P. aeruginosa, S. pneumoniae, M. tuberculosis, C.
albicans, and A. fumigatus. This allowed us to identify several
pathways that were induced in a pathogen-specific manner. The
S. pneumoniae-specific transcriptome revealed the repression
of genes involved in IFN signaling and antigen presentation,
while P. aeruginosa-specific genes were enriched for the TNF-
α and cytokine signaling pathways. These findings suggest
that pathogen-specific responses in leukocytes could influence
pathophysiology found sepsis patients, partly underlying the
heterogeneity observed in sepsis. However, our analysis also
identified core pathways that were induced in PBMCs in response
to all pathogens as reported before (4). This suggests that the
common genes that correspond to core pathways such as antigen
presentation, cell-cell signaling, immune regulatory pathways,
are absolutely necessary to fight against all types of bacterial or
fungal infections. Importantly, we found a strong enrichment
of genes involved in leukocyte interaction with endothelial
cells and cellular matrix. This finding suggests that the core
leukocyte response to pathogens converges on endothelial cells.
Interestingly, as suggested by our previous study (23), genes
located nearby genetic variants that are associated with sepsis
are enriched for immune and endothelial pathways. Therefore,
studying leukocyte-endothelium cross-talk is critical in the
context of sepsis and potentially can explain sepsis heterogeneity.
Second, by characterizing the global transcriptional response
of endothelial cells to sepsis causing pathogens, we emphasize
the role of leukocyte-endothelial cross-talk during infections.
Although endothelial cells are not considered classical immune
cells, HUVECs have been shown to express TLR4 and RIG-I,
pattern recognition receptors for LPS-mediating responses to
regulate cytokine responses and endothelial activation (8, 9).
We indeed observed very strong activation of endothelial
transcriptional pathways in response to LPS in comparison to
direct stimulation of endothelial cells using other bacterial and
fungal pathogens. These findings are in line with the observation
of Filler et al. who showed that heat-killed C. albicans were
not sufficient to induce strong expression of cytokines and
adhesion molecules in endothelial cells in comparison to live
and germinating C. albicans (24). Our study mapped the whole
transcriptomic response to various pathogens including heat-
killed S. pneumoniae and heat-killed C. albicans, which to our
understanding, has not been reported before. Moreover, we
showed that endothelial responses to Gram-positive bacteria
and fungi are strongly affected by inflammatory signals from
activated leukocytes. More than 66% of responding genes in
HUVECs stimulated by PBMC humoral signals are shared across
all stimuli. Although we expected to find activation of endothelial
cells in response to circulatory mediators released by leukocytes,
it was interesting to find a strong induction of IFN pathways
together with IL-1 and TNF-α pathways. Whereas, IL-1 and
TNF-α pathways have been investigated as a strategy to improve
sepsis outcome, by studying the impact of humoral signals
from leukocytes on endothelial cells, we observed a stronger
enrichment of IFN-α/β and IFN-γ signaling than IL-1 and TNF-
α signaling in endothelial cells. This suggests that, together with
IL-1 and TNF-α, IFN pathways can result in aberrant responses
within endothelial cells. Moreover, by neutralizing IL-1 with
Anakinra and TNF-αwith TNF-α blocking antibody in leukocyte
humoral signals, we confirmed that IL-1 and TNF-α are themajor
mediators involved in activating endothelial cells. Intriguingly,
we also identified different downstream mechanisms regulating
endothelial adhesion molecules such as E-selectin, VCAM-1, and
ICAM-1. E-selectin is strongly regulated by IL-1 and TNF-α,
whereas ICAM-1 and VCAM-1 are driven more by TNF-α. We
also found that activated endothelial cells are a major source of
IL-6 production, corroborating a previous study (25).
Interestingly, even after blocking IL-1 and TNF-α, we were
able to identify strong activation of IFN-α/β and IFN-γ pathways
in endothelial cells. Several studies have already identified IFN-
α/β pathway in leukocytes in response to bacteria (26) and fungi
(27). In endothelial cells, although, IFN-α/β has been shown
to promote endothelial proliferation in vitro (28), and reduce
intracellular NO generation and impair fibrinolysis of HUVECs
in vitro (29), the precise impact of IFN-α/β on endothelial
function in the context of bloodstream infection or sepsis is
not clear. Since NO production from the endothelium maintains
blood pressure and blood flow (30) and reduced NO bioactivity is
associated with sepsis severity (31), it will be relevant to study the
effect of neutralizing IFNs to improve sepsis outcomes. In fact, it
is currently being discussed whether IFN-β should be neutralized
during the hyper-inflammatory phase in sepsis patients due to its
contribution to pro-inflammation and/or whether it needs to be
supplemented while patients are in the hypo-inflammatory phase
given its ability to restore and reverse immunosuppression (32).
Further studies should investigate which inflammatory
mediator(s) from activated leukocytes induced IFN-α and IFN-β
signaling in endothelial cells. We observed the mRNA expression
of IFN-α/β receptors (IFNAR1, IFNAR2) in endothelial cells
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across all the stimulatory pathogens we studied, but could not
detect IFN-α or IFN-β in the medium of activated leukocytes
(data not shown). Nevertheless, we observed a high amount of
IFN- γ released by leukocytes in response to C. albicans and
also increased RNA expression of IFN- γ receptor (IFNGR1) in
endothelial cells. We also observed that C. albicans-stimulated
leukocytes secrete the most potent mix of mediators for inducing
endothelial activation, which suggests that C. albicans could
be a good model to represent the broad impact of leukocyte
signals on endothelial cells. One could use it, for example, as
a model to study the interaction of leukocytes and endothelial
cells with more functional assays to study the biological effect of
IFN-activation on endothelial function.
Interestingly, we also observed that TLR3 (TLR-3), DDX58
(RIG-I), and NLRC5, together with IRF-1, -2, -3, and -7 were
highly expressed in endothelial cells exposed exclusively to C.
albicans- and S. pneumoniae-derived supernatants. RIG-I and
IRF-1 are important mediators of endothelial activation in
response to LPS and TNF-α as described previously (9, 33, 34).
Nevertheless, what regulates the expression of these upstream
molecules, either cytosolic DNA or other mediators present in
the supernatants, remains elusive.
One of the limitation of our study is the use of heat-killed
pathogens, which mounts, to some extent, differences in the
host response to pathogens due to the exposure of ligands and
the lack of dynamic interactions between the pathogens and
the host cells. It has been shown that heat-killed pathogens
(such as Bordetella pertussis) induce consistently high RNA
expression of inflammatory cytokines (such as TNF-α, MIP-
1β, IL1-α, and IL-1β) over time, whereas live bacteria induce
a transient increase of those genes that was followed by gene
suppression (35). Live bacteria, on the other hand, can induce
inflammasome activation, altering the amount of secreted IL-1β
inmacrophages and dendritic cells whereas heat-killed pathogens
cannot (36). In our study, although each heat-killed pathogen
induced the responses in PBMCs (at RNA levels), which match
with the typically known pathogenic toxins and ligands, to what
extent the differences between the heat-killed and live pathogens
affect the interaction between leukocytes and endothelial cells
remains to be further investigated.
Future studies, if possible, should also investigate the host
response to live attenuated pathogens or heat-killed pathogen
lysate supplemented with bacterial RNA (36). Secondly, although
we characterized the global transcription and protein expression
levels during leukocyte and endothelial cells cross-talk, follow-
up studies are needed to understand the consequences of
up-regulated IFN signaling in endothelial cells during sepsis.
In addition, it will be important to also study the impact
of interaction between neutrophils together with leukocytes
and endothelial cells in human-relevant model systems. In
conclusion, our work suggests that activation of IFN pathways
in endothelial cells plays an important role in the context
of sepsis.
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